Alto Pharmacy

Alto Pharmacy is a technology company.

Active

Updated: Feb 17, 2026 ·

Recent News & Mentions

Jan 1, 2020FundingAlto Pharmacy - Series D Dec 1, 2018FundingAlto Pharmacy - Series C Jun 1, 2017FundingAlto Pharmacy - Series B Jun 1, 2016FundingAlto Pharmacy - Series A Jun 1, 2015FundingAlto Pharmacy - Seed

Financial History

Alto Pharmacy has raised $323.6M across 5 funding rounds. Most recently, it raised $250.0M Series D in January 2020.

Total Raised

$323.6M

Valuation

N/A

Funding Rounds Raised

Date	Round	Other Investors
Jan 1, 2020	$250.0M Series D	Hack VC, Javelin Venture Partners, MHS Capital, Turtle Ventures
Dec 1, 2018	$50.0M Series C	Flint Capital, Glilot Capital Partners, Greenoaks Capital, Hack VC, Javelin Venture Partners, MHS Capital, NFX, Norwest Venture Partners, OurCrowd, Turtle Ventures, UpWest, Prescott Watson
Jun 1, 2017	$17.0M Series B	B Capital Group, Crosslink Capital, Kevin Ding, DST Global, Goat Capital, Greenoaks Capital, Griffin Gaming Partners, Hack VC, Insight Partners, Javelin Venture Partners, Mango Capital, Meritech Capital Partners, MHS Capital, QueensBridge Venture Partners, Recursive Ventures, Storm Ventures, Turtle Ventures, UpHonest Capital, Y Combinator, Anthony Saleh, Emmett Shear, Evan Cheng, John Kobs, Kevin Lin, Kyle Vogt, Marc Benioff, Mo El-Bibany, Peter Sonsini
Jun 1, 2016	$6.0M Series A	B Capital Group, Crosslink Capital, Kevin Ding, Hack VC, Insight Partners, Javelin Venture Partners, Mango Capital, MHS Capital, Recursive Ventures, Turtle Ventures, UpHonest Capital, Y Combinator, Evan Cheng, Marc Benioff, Mo El-Bibany
Jun 1, 2015	$600K Seed	Afore Capital, Alsop Louie Partners, Amplify Partners, C2 Investment, Coelius Capital, Electric Capital, Felicis Ventures, Founder Collective, Goat Capital, Maven Ventures, NKM Capital, Quiet Capital, Signia Venture Partners, Spark Capital, Trucks Venture Capital, Y Combinator, Colin Carrier, Emmett Shear, John Collison, Sam Altman, Satya Nadella, Tikhon Bernstam

Financial History

Alto Pharmacy has raised $323.6M across 5 funding rounds.

Total Raised

$323.6M

Valuation

N/A

Deep Dive

High-Level Overview

Alto Pharmacy is a technology-driven pharmacy company that builds an integrated platform combining AI, automation, and pharmacist expertise to streamline prescription fulfillment, delivery, and patient care. It serves patients seeking convenient home delivery of medications, physicians managing workflows, and enterprise partners like telehealth providers, hubs, and payors, solving problems like slow prescription processing, high costs, manual errors, and poor adherence through high-volume fulfillment centers and tools like the Alto patient app and Alto Connect.[1][2][3]

Key offerings include Alto Technologies, launched in 2024, featuring Alto Complete™ (an end-to-end hub and dispensing platform), Alto Hub+™ (non-dispensing automation for billing and access), and retail/specialty dispensing with same-day delivery. This has driven growth momentum: 41% of prescriptions ready in 2 minutes, 70-75% in 60 minutes, $220M+ in patient savings via automated insurance and coupons, and 85% app adoption, enabling one fulfillment center to serve as many as 400 chain pharmacies.[1][2][3]

Origin Story

Founded in 2015 in San Francisco, Alto Pharmacy emerged from founders' recognition that legacy pharmacy tech—reliant on manual processes—delivered slow fills, high costs, and limited delivery, failing patients' needs for quality care.[1][3] Over nearly a decade, Alto developed its proprietary Alto OS™ operating system in-house to prioritize patients, blending tech efficiencies with pharmacist input while expanding from direct-to-consumer delivery in metro areas like San Francisco (7M people), Los Angeles, and Orange County (20M people) to high-volume fulfillment centers.[1][3]

Pivotal moments include building specialized expertise in complex therapeutics (e.g., fertility, psychiatry, HIV) and launching Alto Technologies in October 2024 to license its platform enterprise-wide, evolving from a patient-facing pharmacy to a B2B tech provider after proving internal traction like rapid delivery and massive savings.[1][4]

Core Differentiators

Alto stands out in pharmacy through automation-first tech that replaces manual workflows, enabling superior speed, cost, and adherence:

Speed and Efficiency: Automates intake (80%), billing (88%), and processing—41% ready in 2 minutes vs. days for traditional hubs; one center matches 400 chain locations with smaller teams.[1][2][5]
Patient-Centric Tools: Intuitive app (85% adoption) for self-service scheduling, management, and messaging; real-time tracking, multichannel onboarding, and consolidated deliveries for multi-med patients.[2][3][4]
Enterprise Flexibility: Alto Complete™, Hub+™, and Dispensing solutions are configurable with APIs for customization, benefits investigation, prior auths, and data analytics—at lower costs than legacy systems.[1][2][5]
Provider Support: Alto Connect cuts clinic admin by 20 hours/physician/week, reducing errors and boosting adherence via seamless e-prescription workflows.[3][4]
Cost and Access: $220M+ savings through auto-coupons/insurance; supports DTC telehealth with full lifecycle control, bypassing traditional channels.[1][4][5]

Role in the Broader Tech Landscape

Alto rides the digital health and telehealth boom, capitalizing on post-pandemic demand for convenient, tech-enabled care amid rising chronic disease management and specialty drug needs. Timing aligns with AI/automation maturation in healthcare, where outdated pharmacy systems create friction—Alto's platform addresses this by modernizing the $500B+ U.S. pharmacy market with end-to-end digitization.[1][3]

Market forces favoring Alto include payer pressures for adherence/cost reduction, telehealth growth needing integrated fulfillment, and specialty "lite" opportunities via low-cost hubs. It influences the ecosystem by enabling partners (manufacturers, payors, DTC brands) to scale access, cut admin burdens, and unlock data insights, potentially disrupting chains like CVS while humanizing care through pharmacist-tech synergy.[1][2][4][5]

Quick Take & Future Outlook

Alto's pivot to Alto Technologies positions it for B2B expansion, licensing its proven platform to telehealths, hubs, and networks amid AI-driven pharmacy modernization. Upcoming trends like personalized medicine, further automation (e.g., advanced AI for adherence), and regulatory tailwinds for DTC delivery will accelerate growth, potentially multiplying enterprise partnerships and nationwide scaling beyond current metros.[1][2]

As pharmacy tech evolves, Alto could redefine standards for convenience and equity in medication access, evolving from disruptor to infrastructure layer—much like how its 2015 origins transformed patient experiences, now empowering the industry's shift to patient-first efficiency.

Sources

Frequently Asked Questions

How much funding has Alto Pharmacy raised?

Alto Pharmacy has raised $323.6M in total across 5 funding rounds.

Who are Alto Pharmacy's investors?

Alto Pharmacy's investors include Hack VC, Javelin Venture Partners, MHS Capital, Turtle Ventures, Flint Capital, Glilot Capital Partners, Greenoaks Capital, NFX, Norwest Venture Partners, OurCrowd, UpWest, Prescott Watson.